SCHEMBL8349109

SCHEMBL8349109

Nc1cccc(Nc2nccc(-c3cccc(NC(=O)CN4CCOCC4)c3)n2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 5/20 0.61
JAK3 P52333 4/20 0.61
JAK1 P23458 2/20 0.61
TYK2 P29597 3/20 0.56
ABL1 P00519 4/20 0.54
BCR P11274 3/20 0.54
MAP4K4 O95819 2/20 0.54
SRC P12931 3/20 0.54
EGFR P00533 2/20 0.54
PRKACA P17612 1/20 0.54
PRKACG P22612 1/20 0.54
PRKACB P22694 1/20 0.54
CAMK2D Q13557 2/20 0.53
ROCK2 O75116 1/20 0.53
ROCK1 Q13464 1/20 0.53
SMG1 Q96Q15 4/20 0.51
CDK1 P06493 3/20 0.51
CDK2 P24941 3/20 0.51
MTOR P42345 1/20 0.51
ABL2 P42684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4382875 0.93 JAK2 (0.63) JAK2JAK3JAK1TYK2ABL1
SCHEMBL14348343 0.89 ABL1 (0.54) JAK2JAK3JAK1TYK2ABL1
SCHEMBL4897217 0.87 ABL1 (0.68) JAK2JAK3JAK1ABL1BCR
SCHEMBL4902913 0.86 ABL1 (0.57) JAK2JAK3JAK1TYK2ABL1
SCHEMBL8349351 0.84 JAK2 (0.58) JAK2JAK3ABL1BCRSRC
SCHEMBL4903833 0.83 SYK (0.57) JAK2JAK3JAK1ABL1BCR
SCHEMBL14348362 0.82 JAK2 (0.56) JAK2JAK3ABL1BCRSRC
SCHEMBL3203453 0.81 ALDH1A1 (0.72) MAP4K4ALDH1A1HTT
SCHEMBL14348363 0.81 JAK2 (0.64) JAK2JAK3JAK1TYK2SMG1
SCHEMBL14348354 0.81 JAK2 (0.54) JAK2JAK3ABL1BCRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 US disclosed
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 US disclosed
WO-2004041789-A1 COMPOSITIONS USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-05-21 WO disclosed